As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

As part of a study conducted in collaboration with the University of Padua, the data collected by the Sports Medicine ULSS 2 division of Veneto included the screening of more than 22,000 young athletes for heart disease, publishing its finding in the European Heart Journal under Value of screening for the risk of sudden cardiac death in young competitive athletes.

Conducting the research included a team under Patrizio Sarto - Director of Sports Medicine at ULSS 2, in collaboration with Domenico Corrado - Director of the UOSD Genetic Centre for Arrhythmic Cardiomyopathies and Sports Cardiology, and Alessandro Zorzi from the Department of Thoracic and Vascular Sciences and Public Health of the University of Padua.

Dr Sarto explains, “The study includes the scientific data collected by our team on 22,324 athletes between the ages of 7 and 18 who have undergone 65,397 medical evaluations over the years. Our screening modality differs from that proposed in other countries such as the United Kingdom, where young English football players undergo a single cardiovascular evaluation at the age of 16.  Young Italian athletes are evaluated at a very young age and repeat the evaluation annually, this allows for the very early identification of cardiovascular diseases at risk of sudden cardiac death (SCD) during sporting activities, whereas the first evaluation is unable to highlight the pathology, subsequent checks are essential.  Screenings conducted in Italy aim to identify pathologies with particular reference to the inclusion of an electrocardiogram (ECG), the appropriate starting age and frequency of repeat cardiovascular evaluations, and the eligibility of athletes diagnosed with cardiovascular diseases at risk of SCD.

A very important fact that emerged from the study is that as many as 74% of cardiovascular diseases presenting this risk were diagnosed in children and young people under the age of 16.  Thanks to the Italian screening model, the lives of 69 young people were potentially saved. Out of 22,324 athletes evaluated, only one suffered from cardiac arrest during a sports activity and survived thanks to cardiopulmonary resuscitation and access to a defibrillator. "This is a very complex case because, despite the many tests performed, it has not yet been possible to identify the cause of the cardiac arrest," says Sarto.

A fact that emerges from the study - adds the Zorzis - is the fundamental role of the stress test in the medical-sports evaluation. In Italy, stress tests are always performed during the medical-sports visit, while abroad it is usually done at resting ECG.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

The European Commission announces the winners of the Horizon Europe - Action Marie Skłodowska-Curie Postdoctoral Fellowships 2022 Call (MSCA-PF-2022), awarding the University of Padua with top results for 15 projects set to receive European funding and 13 projects placed on a reserve list.

UniPD Departments set to receive funds include the Department of Chemical Sciences (5 projects), the Department of Historical and Geographic Sciences and the Ancient World (4 projects), the Department of Geosciences (2 Fellowships), and 1 funded project each for the Department of Biology, Department of Molecular Medicine, Department of Biomedical Sciences, and the Department of Comparative Biomedicine and Food Science.

Established as an interdisciplinary and multidisciplinary institute, the University of Padua attracts students thanks to its international level of excellent research and by offering a wide range of possibilities for those interested in undertaking research activities through the pursuit of innovative ideas.

Since 2014, 106 post-doc research awardees of the Marie Skłodowska-Curie Action have chosen the University of Padua as their host institute. This growing community of young talent serves to prove the attractiveness of the University of Padua as an avant-garde institution in the various sectors of scientific research.

Of the 15 projects financed for a total of 3,338,343.30 euros, 7 are European Postdoctoral Fellowships (those carrying out projects in the EU or countries associated with Horizon Europe) and 8 are Global Postdoctoral Fellowships (those carrying our projects for 1 to 2 years outside the EU or countries associated with Horizon Europe before returning to Europe).

In addition to the 15 funded UniPD projects, 19 other projects scored equal to or above 85% and were awarded the MSCA Seal of Excellence.  While such projects are not funded by Horizon Europe due to budgetary constraints they do receive support in securing alternative funding from national or regional authorities. In this case, the University of Padua offers funding thanks to the MSCA Seal of Excellence @ UNIPD initiative. As a first of its kind in Italy, the initiative awards a grant of 50,000 euros per year, through a dedicated call for applications, to projects that designate the University of Padua as the host institution. The initiative aims to encourage wider participation by the most qualified international researchers in the Marie-Skłodowska-Curie Postdoctoral Fellowship Calls under Horizon Europe.

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)

Fondazione AIRC per la ricerca sul cancro ha approvato l’erogazione di fondi per 37 progetti e borse di studio presso l’Università di Padova, afferenti a diverse aree scientifiche, con un sostegno complessivo per il 2023 di 4.063.757,47 euro.
Si tratta di fondi destinati alla ricerca contro il cancro, ottenuti dai ricercatori tramite il processo di valutazione di AIRC, basato sulla selezione trasparente e indipendente del merito scientifico di ogni progetto.

AIRC sostiene, nell’ambito dei programmi “5 per mille”, le ricerche di Matteo Fassan, Valentina Guarnieri, Stefano Piccolo e Rosario Rizzuto.

La maggior parte dei fondi AIRC è destinata a progetti di ricerca della durata di cinque anni. Di questi, i progetti di tipo “Investigator Grant” sono guidati da ricercatrici e ricercatori affermati e i fondi assegnati coprono il costo della ricerca più quello del personale in formazione che vi lavora. All’Università di Padova, nel 2023, iniziano sei nuovi progetti selezionati da AIRC e condotti da Marco Agostini, Silvia Bresolin, Michelangelo Cordenonsi, Maria Vittoria Dieci, Massimo Santoro e Ildikò Szabò. Questi si aggiungono ai progetti già in corso e rinnovati, condotti da Paolo Bernardi, Vincenzo Ciminale, Sirio Dupont, Monika Fuxreiter, Arianna Loregian, Fabrizio Mancin, Maria Pennuto, Stefano Piccolo, Erich Piovan, Sara Richter, Chiara Romualdi, Antonio Rosato, Marco Sandri, Claudia Sissi, Gyorgy Szabadkai, Silvio Tosatto, Livio Trentin e Gianpietro Viola.

Le “Borse per l’Italia” sono assegnate a giovani ricercatrici e ricercatori, a volte anche neolaureati, prima o dopo avere conseguito un dottorato. Si tratta di borse di formazione dedicate all’apprendimento delle basi della ricerca, che offrono la possibilità di acquisire esperienza in Italia presso un laboratorio d’eccellenza. I beneficiari presso l’Università di Padova sono Maddalena Benetton e Mouawad Nyala.

Il “My First AIRC Grant” (MFAG) è invece assegnato a ricercatori che abbiano già maturato un’esperienza di ricerca oncologica in Italia o all’estero. I fondi offrono la possibilità di sperimentare la conduzione del proprio progetto in una struttura italiana di eccellenza e di diventare progressivamente autonomi e indipendenti. A Padova i ricercatori già sostenuti con un MFAG, oltre alla new entry per il 2023 Patrizia Romani, sono: Vincenzo Amendola, Enrica Calura, Gaia Codolo, Luigi Leanza e Marco Montagner.

I grant Start-Up sono assegnati a ricercatori eccellenti che abbiano già dimostrato una significativa esperienza scientifica in un laboratorio all’estero e permettono di gestire il lavoro di ricerca in assoluta autonomia avviando un laboratorio in Italia. All’Università di Padova Francesco Boccalatte può lavorare grazie a un grant Start-Up.

Le schede dei nuovi progetti 2023 (file pdf)